Australian researchers create weekly Parkinson's injection, replacing daily pills

Researchers at the University of South Australia have developed a once-weekly injectable gel containing levodopa and carbidopa, offering a potential new treatment for Parkinson's disease. This could replace daily pills. The biodegradable gel provides a steady release of medication over seven days, potentially improving patient adherence and reducing side effects associated with fluctuating drug levels. The formulation showed promising results in lab tests. This innovation aims to simplify treatment for the millions affected by Parkinson's, potentially leading to more stable symptom control and a better quality of life. Clinical trials are planned.